AGIOAgios Pharmaceuticals, Inc.Not started yet
A Study to Investigate AG-236 in Subjects ≥18 Years of Age With Polycythemia Vera
Polycythemia Vera
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2/3
- Patients
- 245 (planned)
- Started
- Nov 2026
- Main results expected
- Aug 2030
- Fully finished
- Aug 2032
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Phase 2 and Phase 3: Percentage of Subjects With No Phlebotomy and Absence of Phlebotomy Eligibility
Measured over: Week 13 Through Week 26
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07859423 · record last updated 2026-10-13 · checked 2026-11-09 15:47 UTC